BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 16459687)

  • 1. [Place of duloxetine in the treatment of stress urinary incontinence].
    RouprĂȘt M; Richard F; Chartier-Kastler E
    Prog Urol; 2005 Sep; 15(4):689-92. PubMed ID: 16459687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence.
    van Kerrebroeck P; Abrams P; Lange R; Slack M; Wyndaele JJ; Yalcin I; Bump RC;
    BJOG; 2004 Mar; 111(3):249-57. PubMed ID: 14961887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duloxetine: a new approach for treating stress urinary incontinence.
    Moore K
    Int J Gynaecol Obstet; 2004 Jul; 86 Suppl 1():S53-62. PubMed ID: 15302567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Duloxetine versus placebo in the treatment of stress urinary incontinence.
    Norton PA; Zinner NR; Yalcin I; Bump RC;
    Am J Obstet Gynecol; 2002 Jul; 187(1):40-8. PubMed ID: 12114886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and noradrenaline reuptake inhibitors (SNRI) for stress urinary incontinence in adults.
    Mariappan P; Ballantyne Z; N'Dow JM; Alhasso AA
    Cochrane Database Syst Rev; 2005 Jul; (3):CD004742. PubMed ID: 16034945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence.
    Dmochowski RR; Miklos JR; Norton PA; Zinner NR; Yalcin I; Bump RC;
    J Urol; 2003 Oct; 170(4 Pt 1):1259-63. PubMed ID: 14501737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial.
    Millard RJ; Moore K; Rencken R; Yalcin I; Bump RC;
    BJU Int; 2004 Feb; 93(3):311-8. PubMed ID: 14764128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Duloxetine, a serotonin and noradrenaline reuptake inhibitor (SNRI) for the treatment of stress urinary incontinence: a systematic review.
    Mariappan P; Alhasso A; Ballantyne Z; Grant A; N'Dow J
    Eur Urol; 2007 Jan; 51(1):67-74. PubMed ID: 17014950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duloxetine: mechanism of action at the lower urinary tract and Onuf's nucleus.
    Jost W; Marsalek P
    Clin Auton Res; 2004 Aug; 14(4):220-7. PubMed ID: 15316838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Duloxetine. A new preparation for patients with urinary incontinence].
    Walter S
    Ugeskr Laeger; 2005 Nov; 167(48):4553-5. PubMed ID: 16324435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological treatment of women awaiting surgery for stress urinary incontinence.
    Cardozo L; Drutz HP; Baygani SK; Bump RC
    Obstet Gynecol; 2004 Sep; 104(3):511-9. PubMed ID: 15339761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Duloxetine: in stress urinary incontinence.
    McCormack PL; Keating GM
    Drugs; 2004; 64(22):2567-73; discussion 2574-5. PubMed ID: 15516154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine: a serotonin-noradrenaline re-uptake inhibitor for the treatment of stress urinary incontinence.
    Zinner NR
    Expert Opin Investig Drugs; 2003 Sep; 12(9):1559-66. PubMed ID: 12943499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of duloxetine in elderly women with stress urinary incontinence or stress-predominant mixed urinary incontinence.
    Schagen van Leeuwen JH; Lange RR; Jonasson AF; Chen WJ; Viktrup L
    Maturitas; 2008 Jun; 60(2):138-47. PubMed ID: 18547757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on duloxetine for the management of stress urinary incontinence.
    Basu M; Duckett JR
    Clin Interv Aging; 2009; 4():25-30. PubMed ID: 19503763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Duloxetine for male stress incontinence.
    Chapple CR
    Eur Urol; 2006 Jun; 49(6):958-60. PubMed ID: 16522351
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacotherapy for stress urinary incontinence.
    Castro-Diaz D; Amoros MA
    Curr Opin Urol; 2005 Jul; 15(4):227-30. PubMed ID: 15928510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Duloxetine: new drug. For stress urinary incontinence: too much risk, too little benefit.
    Prescrire Int; 2005 Dec; 14(80):218-20. PubMed ID: 16400743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Successful phase III study with serotonin-noradrenaline reuptake inhibitor. Soon a drug to control stress incontinence].
    MMW Fortschr Med; 2004 Feb; 146(7):59. PubMed ID: 15347056
    [No Abstract]   [Full Text] [Related]  

  • 20. The treatment of urinary incontinence with Duloxetine.
    Basu M; Duckett J
    J Obstet Gynaecol; 2008 Feb; 28(2):166-9. PubMed ID: 18393011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.